7
Total investments
1
Early stage
2
Mid stage
2
Late stage
7y
Years active
Portfolio
6 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Oct 2022
Apricity is the UKs first virtual fertility clinic, a next-generation experience for less stress and more success
1 in 6 couples and over 3 million people in the UK struggle to conceive. Treatment exists, but is often associated with stress and uncertainty. We dont believe it has to be this way.
Apricity challenges the traditional fertility treatment journey, leveraging AI and technology with personalised human care to create a truly patient-centric experience.
We are reimagining fertility care, maximising chances of pregnancy success and supporting patients at every step.
▶️ Virtual clinic model with at home diagnostic testing and treatments - only visit a clinic twice rather than up to 10 times
▶️ Dedicated fertility advisor available 7/7 during extended hours for support, guidance and administrative help
▶️ Apricity app offers instant access to a dedicated medical team & helps to reduce errors with medication reminders and treatment guidance
▶️ Our position at the forefront of AI fertility research helps people understand their chances of success while fuelling integral industry research.
The Apricity Fertility Benefit for Corporates:
Infertility is one of the most difficult experiences people can go through. It’s also more important than ever in the workplace, and incredibly difficult for staff. It can creates issues for employers, as a cause of massive stress, gaps in productivity, absenteeism, and even resignations.
Apricity partners with world-class companies who truly care for their employees and offer:
▶️ Educational webinars for employees to understand how to navigate the complex world of fertility
▶️ 1:1 sessions with a senior fertility nurse
▶️ A-Z fertility solutions, from consultations and diagnostics to full fertility treatments such as IVF
To find out how we can create tailor-made programs that empower your staff and support retainment, get in touch at corporate@apricity.life
Board Observer
Jun 2022
Real-World Data you can trust, at scale.
EHR-derived insights from a federated hospital network.
High-quality, validated, cNLP-enriched medical data, supported by a secure European infrastructure.
Board Member
Aug 2021
Intelligencia uses Artificial Intelligence to de-risk drug development. Our platform focuses on estimating the risk of clinical trials, and interpreting the multitude of factors that contribute to that risk. We therefore aim to bridge the gap between innovation and risk reduction, with the ultimate goal of bringing novel therapies to patients faster.
Our interdisciplinary team of software engineers, AI practitioners, scientists, and drug developers brings together and interprets disparate data across the life sciences industry. Our platform offers a suite of functionalities that provide unprecedented data clarity and Machine-Learning fueled predictions to enable critical decision making.
We currently work with several of the largest global pharmaceutical companies and mid-size and smaller biotechnology companies.
Diseases will impact nearly every individual. At Intelligencia AI, we work to make a difference.
Investor
Feb 2021
9amHealth is complete cardiometabolic care—a first-of-its-kind, whole-body approach to preventing and treating diabetes, obesity, high cholesterol, and hypertension. We partner with businesses looking to provide effective health benefits to their members while reducing overall healthcare costs.
9amHealth was founded in 2021 by the team behind mySugr and is backed by 7Wire Ventures, Human Capital, Founders Fund, and Define Ventures. More at www.join9am.com.
Board Observer
Dec 2019
We empower everyone to change their eating and lifestyle-related habits, improving their long-term health through personalised support and technology. We partner with health insurers, healthcare systems, and doctors to provide everyone with easy access to the care they need.
Experience · 12 entries
All (12)
Investments (7)
Founder (1)
Board (5)
2023
Managing Partner
Oct 2023
3pai Capital总部位于美国纽约。公司的使命是推进医疗大健康产业的数字化,让更多消费者享有个性化的健康管理。三拍资本的合伙人在过去十三年里,专注于医疗大健康领域的投资,并为德国、瑞士及荷兰的投资者提供医疗健康技术领域的投资咨询。三拍资本经常与其他投资者联合投资于创新医疗大健康公司,并为其看好的公司提供融资咨询。
2022
Board Member
Oct 2022
Apricity is the UKs first virtual fertility clinic, a next-generation experience for less stress and more success
1 in 6 couples and over 3 million people in the UK struggle to conceive. Treatment exists, but is often associated with stress and uncertainty. We dont believe it has to be this way.
Apricity challenges the traditional fertility treatment journey, leveraging AI and technology with personalised human care to create a truly patient-centric experience.
We are reimagining fertility care, maximising chances of pregnancy success and supporting patients at every step.
▶️ Virtual clinic model with at home diagnostic testing and treatments - only visit a clinic twice rather than up to 10 times
▶️ Dedicated fertility advisor available 7/7 during extended hours for support, guidance and administrative help
▶️ Apricity app offers instant access to a dedicated medical team & helps to reduce errors with medication reminders and treatment guidance
▶️ Our position at the forefront of AI fertility research helps people understand their chances of success while fuelling integral industry research.
The Apricity Fertility Benefit for Corporates:
Infertility is one of the most difficult experiences people can go through. It’s also more important than ever in the workplace, and incredibly difficult for staff. It can creates issues for employers, as a cause of massive stress, gaps in productivity, absenteeism, and even resignations.
Apricity partners with world-class companies who truly care for their employees and offer:
▶️ Educational webinars for employees to understand how to navigate the complex world of fertility
▶️ 1:1 sessions with a senior fertility nurse
▶️ A-Z fertility solutions, from consultations and diagnostics to full fertility treatments such as IVF
To find out how we can create tailor-made programs that empower your staff and support retainment, get in touch at corporate@apricity.life
Board Member
Oct 2022
Mediktor was founded in Spain in 2011 by Oscar García-Esquirol, an intensive care provider, and Cristian Pascual, an industrial engineer. It is the most advanced clinically validated AI-based medical assistant for triage and pre-diagnosis that guides patients to the right level of care at the right time – improving access while enabling more efficient care navigation. Powered by a sophisticated AI engine that enables users to converse naturally in several languages, Mediktor’s white-labeled SaaS is omnichannel and can be easily embedded into any interface (web, mobile, desktop). Mediktor’s customers include health plans, hospital and health systems, telehealth, and pharmaceutical companies.
Board Observer
Jun 2022
Real-World Data you can trust, at scale.
EHR-derived insights from a federated hospital network.
High-quality, validated, cNLP-enriched medical data, supported by a secure European infrastructure.
2021
Board Member
Aug 2021
Intelligencia uses Artificial Intelligence to de-risk drug development. Our platform focuses on estimating the risk of clinical trials, and interpreting the multitude of factors that contribute to that risk. We therefore aim to bridge the gap between innovation and risk reduction, with the ultimate goal of bringing novel therapies to patients faster.
Our interdisciplinary team of software engineers, AI practitioners, scientists, and drug developers brings together and interprets disparate data across the life sciences industry. Our platform offers a suite of functionalities that provide unprecedented data clarity and Machine-Learning fueled predictions to enable critical decision making.
We currently work with several of the largest global pharmaceutical companies and mid-size and smaller biotechnology companies.
Diseases will impact nearly every individual. At Intelligencia AI, we work to make a difference.
Show all 12 entries ↓
Investment activity
2019–2022 · 7 investments
Recent (last 2 years)Earlier
